Digital Respiratory Device Market Is Booming across the Globe Explored in Latest Report 2020-2025 | 3M, GSK, Adherium, Capsule Tech, Novartis, Propeller Health, Teva, AstraZeneca

Global Digital Respiratory Device Market Synopsis:

The report covers a forecast and an analysis of the Digital Respiratory Device Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Digital Respiratory Device Market along with the impact they have on the demand over the forecast period.

The significant key factors driving the growth of the Global Digital Respiratory Device Market are high prevalence of respiratory diseases, increasing aging population across the globe, high prevalence of smoking, rapid growth in urbanization and pollution levels, rising incidence of preterm births, and lifestyle changes. As per the WHO, in 2016, an estimated 251 million cases of chronic obstructive pulmonary diseases were recorded across the world. Moreover, globally, around 339 million people were affected by asthma in 2018. Furthermore, COPD accounts for more than 3 million deaths across the world each year. Rise in prevalence of asthma, COPD, and other respiratory diseases are likely propelling the global market.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/273323 .

On the basis of regional analysis, North America is currently the leading contributor to the global Digital Respiratory Device Market. Factors such as availability of large number of key players, increasing healthcare infrastructure, high adoption rate for advanced technologies, and faster product approvals by the regulatory bodies in the region are driving the growth of the North American Digital Respiratory Device Market. However, the Rest-of-the-World is expected to register the highest CAGR, during the forecast period.

This report contains a complete product overview and its scope in the market to define the key terms and provide the clients a holistic idea of the market and its tendency. It comprehensively evaluates the Global Digital Respiratory Device Market with different perspectives for the purpose of providing a detailed, informative, and accurate analysis of regional growth, competition, market segmentation, and other important aspects.

Global Key Players:

1 3M Health Care

2 Adherium

3 Capsule Technologies

4 Cohero Health

5 Novartis AG

6 Propeller Health

7 Sensiron AG

8 Teva Pharmaceuticals Industries

9 Amiko Digital Health

10 AstraZeneca

11 Boehringer Ingelheim International GmbH

12 GlaxoSmithKline and More…………….

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Digital Respiratory Device Market Report 2020” @ https://www.businessindustryreports.com/buy-now/273323/single .

Product Type Segmentation

1 Sensors

2 Smart Inhalers

3 Nebulizers

Industry Segmentation

1 Smart Inhalers and Nebulizers

2 Chronic Obstructive Pulmonary Disease (COPD)

International Medical Industry News:

GlaxoSmithKline (GSK) (July 07, 2020) - GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine - GSK and Medicago today announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic adjuvant system. CoVLPs mimic the structure of the virus responsible for COVID-19 disease, allowing them to be recognised by the immune system. Use of an adjuvant can be of particular importance in a pandemic situation as it may boost the immune response and reduce the amount of antigen required per dose, allowing more vaccine doses to be produced and therefore contributing to protect more people.

Pre-clinical results with Medicago’s CoVLP vaccine candidate demonstrated a high level of neutralizing antibodies following a single dose when administered with adjuvant.

Phase 1 clinical testing is planned to start in mid-July and will evaluate the safety and immunogenicity of three different dose levels of antigen combined with GSKs pandemic adjuvant and in parallel with an adjuvant from another company, administered on a one- and two-dose vaccination schedule, given 21 days apart.

Subject to successful clinical development and regulatory considerations, the companies aim to complete development and make the vaccine available, in the first half of 2021. Both companies will also evaluate expanding their collaboration to develop a post-pandemic vaccine COVID-19 candidate, should the need arise based on the further development of COVID-19 after the pandemic, and other infectious diseases.

Dr Thomas Breuer, Chief Medical Officer, GSK Vaccines, said: “This agreement paves the way for an innovative vaccine option combining a scalable plant-based antigen technology with an adjuvant which has pandemic dose sparing capability. If successful, it will be a meaningful contributor in the fight against COVID-19. We strongly believe that multiple vaccines are needed, including post-pandemic vaccines. This plant-based technology also shows promise beyond COVID-19 and has the potential to help prevent other infectious diseases.”

Dr Bruce Clark, President and CEO of Medicago, said: “We are about to begin clinical trials with our CoVLP vaccine candidate harnessing GSKs pandemic adjuvant technology against the virus that causes COVID-19. This collaboration with GSK gives us access to a proven adjuvant which could enhance the effectiveness of our candidate vaccine, and also to a depth of scientific experience to support our development efforts.”

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/273323 .

Major Points in Table of Contents:

Global Digital Respiratory Device Market Report 2020

1 Digital Respiratory Device Product Definition

2 Global Digital Respiratory Device Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Digital Respiratory Device Shipments

2.2 Global Manufacturer Digital Respiratory Device Business Revenue

2.3 Global Digital Respiratory Device Market Overview

2.4 COVID-19 Impact on Digital Respiratory Device Industry

3 Manufacturer Digital Respiratory Device Business Introduction

3.1 3M Health Care Digital Respiratory Device Business Introduction

3.2 Adherium Digital Respiratory Device Business Introduction

3.3 Capsule Technologies Digital Respiratory Device Business Introduction

3.4 Cohero Health Digital Respiratory Device Business Introduction

3.5 Novartis AG Digital Respiratory Device Business Introduction

3.6 Propeller Health Digital Respiratory Device Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that holds the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.